Vandy P Stober , Carol S. Trempus , Flavia Galdi , Negin P. Martin , Wesley Gladwell , Michael Cronce , Jeffery S. Cox , Jay D. Keasling , Jonathan Budzik , Shih-Heng Chen , Yosuke Sakamachi , Jian-Liang Li , Christopher A. McGee , Daniel J. Zaccaro , Jane S. Der , Charles J. Tucker , Erica Scappini , Javier Campos Gomez , Steven M. Rowe , Mary K. Cowman , Christina M. Barkauskas , Patty J. Lee , Matthew R Markovetz , Brian Button , David B. Hill , Dorothea A. Erxleben , Adam R. Hall , Jian Liu , Yongmei Xu , Claudio Pedone , Raffaele Antonelli-Incalzi , Sadis Matalon , Rashmin C. Savani , and Stavros Garantziotis
Publications
CEND affiliates are research leaders - publishing new discoveries to accelerate progress against neglected and emerging diseases.

Publications
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study
Sébastien DS Pion a,*, Hugues Nana-Djeunga b, Yannick Niamsi-Emalio b, Cédric B Chesnais a, Hugo Deléglise a, Charles Mackenzie c, Wilma Stolk d, Daniel A Fletcher e, Amy D Klion f, Thomas B Nutman f, Michel Boussinesq a, Joseph Kamgno b
Prevalence of Antimicrobial Resistance Genes and Integrons in Commensal Gram-Negative Bacteria in a College Community
Julia Rubin (1), Kaitlyn Mussio(2), Yuqi Xu (2), Joy Suh(1), and Lee W. Riley(1)
(1) Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA.
(2) Department of Biochemistry and Molecular Biology, College of Life Sciences, Peking University, Beijing, China.
Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya
1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor.
2Sustainable Sciences Institute, Managua, Nicaragua.
3Georgia State University, Atlanta.
4Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia.
5Centro de Salud Sócrates Flores Vivas, Ministerio de Salud, Managua, Nicaragua.
6Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley.
Screening our FDA-Approved and Bioactive Compounds Library for Antiviral Activity against SARS-CoV‑2
Scott B. Biering, Erik Van Dis, Eddie WehriLivia H. Yamashiro,/ Xammy Huu Wrynla, Claire Dugast-Darzacq, Thomas G. W. Graham, Julien R. Stroumza, Guillaume R. Golovkine, Allison W. Roberts, Daniel M. Fines, Jessica N. Spradlin, Carl C. Ward, Teena BajajDustin Dovala, Ursula Schulze-Gamen, Ruchika Bajaj, Douglas M. Fox, Melanie Ott, Niren Murthy, Daniel K. Nomura, Julia Schaletzky, *Sarah A. Stanley*
